Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
60
UBSI Quote, Financials, Valuation and Earnings
Last price:
$37.22
Seasonality move
:
2.36%
Day range:
$36.55 - $37.51
52-week range:
$30.51 - $44.43
Dividend yield:
3.95%
P/E ratio:
13.93x
P/S ratio:
4.83x
P/B ratio:
1.00x
Volume:
946K
Avg. volume:
843.8K
1-year change:
-0.5%
Market cap:
$5.3B
Revenue:
$1B
EPS (TTM):
$2.69
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | $1B | $1B | $1B | $1B | |
| Revenue Growth (YoY) | 41.74% | -2.17% | 3.29% | 0.72% | -1.7% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $333.7M | $342.2M | $300.3M | $309.6M | $308M | |
| Other Inc / (Exp) | $3.2M | $2.7M | $776K | -$7.6M | -$7.7M | |
| Operating Expenses | $325.5M | $342.2M | $300.3M | $309.6M | $308M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $359.7M | $462.9M | $475.8M | $463.8M | $464.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $70.7M | $95.1M | $96.2M | $97.5M | $91.6M | |
| Net Income to Company | $289M | $367.7M | $379.6M | $366.3M | $373M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $289M | $367.7M | $379.6M | $366.3M | $373M | |
| Basic EPS (Cont. Ops) | $2.40 | $2.84 | $2.81 | $2.72 | $2.76 | |
| Diluted EPS (Cont. Ops) | $2.40 | $2.83 | $2.80 | $2.71 | $2.75 | |
| Weighted Average Basic Share | $120M | $129.3M | $134.8M | $134.5M | $134.9M | |
| Weighted Average Diluted Share | $120.1M | $129.5M | $135.1M | $134.8M | $135.2M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $468.3M | $515.2M | $581.3M | $945.2M | $1.1B | |
| Revenue (Reported) | $1B | $1B | $1B | $1B | $1B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $468.3M | $515.2M | $581.3M | $945.2M | $1.1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $280M | $235.5M | $264.7M | $253.2M | $289M | |
| Revenue Growth (YoY) | 57.54% | -15.88% | 12.4% | -4.36% | 14.17% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $96.9M | $78.1M | $73.4M | $80.4M | $78.9M | |
| Other Inc / (Exp) | $2.6M | -$251K | -$405K | -$99K | $521K | |
| Operating Expenses | $96.9M | $78.1M | $73.4M | $80.4M | $78.9M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $134.5M | $101.8M | $122.8M | $108.2M | $106.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $27.6M | $20.1M | $24.4M | $21.4M | $22.6M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $106.9M | $81.7M | $98.3M | $86.8M | $84.3M | |
| Basic EPS (Cont. Ops) | $0.83 | $0.60 | $0.73 | $0.64 | $0.59 | |
| Diluted EPS (Cont. Ops) | $0.83 | $0.60 | $0.73 | $0.64 | $0.59 | |
| Weighted Average Basic Share | $128.6M | $136.1M | $134.4M | $134.8M | $142.3M | |
| Weighted Average Diluted Share | $128.9M | $136.4M | $134.8M | $135.1M | $142.7M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $149.2M | $113.1M | $217.7M | $254.9M | $250.5M | |
| Revenue (Reported) | $280M | $235.5M | $264.7M | $253.2M | $289M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $149.2M | $113.1M | $217.7M | $254.9M | $250.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | $962.5M | $1.1B | $1B | $1.1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $367.3M | $323.4M | $295.6M | $316.5M | $306.4M | |
| Other Inc / (Exp) | $5.6M | -$184K | $622K | -$7.3M | -$7.1M | |
| Operating Expenses | $359.2M | $323.4M | $295.6M | $316.5M | $306.4M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $444.1M | $430.2M | $496.8M | $449.3M | $463.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $88.4M | $87.6M | $100.5M | $94.4M | $92.8M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $355.7M | $342.5M | $396.3M | $354.8M | $370.5M | |
| Basic EPS (Cont. Ops) | $2.78 | $2.60 | $2.94 | $2.62 | $2.70 | |
| Diluted EPS (Cont. Ops) | $2.78 | $2.60 | $2.94 | $2.62 | $2.69 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $528.5M | $479.1M | $686M | $982.4M | $1.1B | |
| Revenue (Reported) | $1.1B | $962.5M | $1.1B | $1B | $1.1B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $528.5M | $479.1M | $686M | $982.4M | $1.1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $280M | $235.5M | $264.7M | $253.2M | $289M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $96.9M | $78.1M | $73.4M | $80.4M | $78.9M | |
| Other Inc / (Exp) | $2.6M | -$251K | -$405K | -$99K | $521K | |
| Operating Expenses | $96.9M | $78.1M | $73.4M | $80.4M | $78.9M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $134.5M | $101.8M | $122.8M | $108.2M | $106.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $27.6M | $20.1M | $24.4M | $21.4M | $22.6M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $106.9M | $81.7M | $98.3M | $86.8M | $84.3M | |
| Basic EPS (Cont. Ops) | $0.83 | $0.60 | $0.73 | $0.64 | $0.59 | |
| Diluted EPS (Cont. Ops) | $0.83 | $0.60 | $0.73 | $0.64 | $0.59 | |
| Weighted Average Basic Share | $128.6M | $136.1M | $134.4M | $134.8M | $142.3M | |
| Weighted Average Diluted Share | $128.9M | $136.4M | $134.8M | $135.1M | $142.7M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $149.2M | $113.1M | $217.7M | $254.9M | $250.5M | |
| Revenue (Reported) | $280M | $235.5M | $264.7M | $253.2M | $289M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $149.2M | $113.1M | $217.7M | $254.9M | $250.5M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2.2B | $3.8B | $1.2B | $1.6B | $2.3B | |
| Short Term Investments | $3B | $4B | $4.5B | $3.8B | $261.5M | |
| Accounts Receivable, Net | $66.8M | $64.5M | $94.9M | $111.4M | $102.4M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $5.2B | $7.9B | $5.8B | $5.5B | $2.7B | |
| Property Plant And Equipment | $245.3M | $279.2M | $270.3M | $277.5M | $267.9M | |
| Long-Term Investments | $3.2B | $4.3B | $4.9B | $4.1B | $3.3B | |
| Goodwill | $1.8B | $1.9B | $1.9B | $1.9B | $1.9B | |
| Other Intangibles | $21M | $23.1M | $21M | $4.6M | $8.9M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $26.2B | $29.3B | $29.5B | $29.9B | $30B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | $176.1M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $142.3M | $128.8M | $160.7M | $196.1M | $176.1M | |
| Long-Term Debt | $864.4M | $817.4M | $2.2B | $1.8B | $540.4M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $21.9B | $24.6B | $25B | $25.2B | $25B | |
| Common Stock | $334.5M | $353.4M | $355M | $355.6M | $356.7M | |
| Other Common Equity Adj | $22.4M | -$4.9M | -$332.7M | -$259.7M | -$223.9M | |
| Common Equity | $4.3B | $4.7B | $4.5B | $4.8B | $5B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $4.3B | $4.7B | $4.5B | $4.8B | $5B | |
| Total Liabilities and Equity | $26.2B | $29.3B | $29.5B | $29.9B | $30B | |
| Cash and Short Terms | $5.2B | $7.8B | $5.7B | $5.4B | $2.6B | |
| Total Debt | $864.4M | $817.4M | $2.2B | $1.8B | $540.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $3B | $2.8B | $1.9B | $1.7B | $2.6B | |
| Short Term Investments | $3.2B | $4.8B | $4.4B | $3.6B | $254.9M | |
| Accounts Receivable, Net | $66.2M | $66.5M | $98.7M | $113.8M | $110.5M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $6.2B | $7.6B | $6.4B | $5.5B | $3B | |
| Property Plant And Equipment | $243.1M | $277.3M | $272.5M | $277.1M | $296.8M | |
| Long-Term Investments | $3.4B | $5B | $4.8B | $4B | $3.3B | |
| Goodwill | $1.8B | $1.9B | $1.9B | $1.9B | $2B | |
| Other Intangibles | $22M | $23.1M | $20M | $4.2M | $39.3M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $27B | $29.4B | $30.2B | $30B | $32.8B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | $176M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $145.2M | $136.4M | $170.1M | $207.7M | $176M | |
| Long-Term Debt | $814.2M | $817.2M | $2.8B | $1.7B | $550.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $22.7B | $24.8B | $25.6B | $25.2B | $27.5B | |
| Common Stock | $335.3M | $354.5M | $355.6M | $356.3M | $377.1M | |
| Other Common Equity Adj | $1.9M | -$141.7M | -$294.1M | -$261M | -$195M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $4.3B | $4.6B | $4.6B | $4.8B | $5.3B | |
| Total Liabilities and Equity | $27B | $29.4B | $30.2B | $30B | $32.8B | |
| Cash and Short Terms | $6.1B | $7.6B | $6.3B | $5.3B | $2.9B | |
| Total Debt | $814.2M | $817.2M | $2.8B | $1.7B | $550.6M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $289M | $367.7M | $379.6M | $366.3M | $373M | |
| Depreciation & Amoritzation | -$16.4M | $7.9M | $23.7M | $23.1M | $10.4M | |
| Stock-Based Compensation | $6M | $8M | $9.9M | $12.5M | $12.1M | |
| Change in Accounts Receivable | $1.1M | $2.6M | -$30.4M | -$16.5M | $9M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $140.4M | $609.5M | $760.8M | $435.2M | $445.5M | |
| Capital Expenditures | $19M | $15.4M | $16.9M | $11.7M | $12.1M | |
| Cash Acquisitions | $629.1M | $39.4M | -- | -- | -- | |
| Cash From Investing | $137.6M | $15.7M | -$3.4B | $39M | $571.5M | |
| Dividends Paid (Ex Special Dividend) | -$162.7M | -$181.3M | -$193M | -$194.7M | -$200.7M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $500M | $500M | $1.9B | $1.5B | $250M | |
| Long-Term Debt Repaid | -$1.8B | -$597.8M | -$520M | -$1.9B | -$1.5B | |
| Repurchase of Common Stock | -$21.3M | -$11.2M | -$79.5M | -$1.4M | -$1M | |
| Other Financing Activities | $1K | -- | -- | -- | -- | |
| Cash From Financing | $1.1B | $923.9M | $105.3M | -$51.9M | -$323.6M | |
| Beginning Cash (CF) | $837.5M | $2.2B | $3.8B | $1.2B | $1.6B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.4B | $1.5B | -$2.6B | $422.3M | $693.3M | |
| Ending Cash (CF) | $2.2B | $3.8B | $1.2B | $1.6B | $2.3B | |
| Levered Free Cash Flow | $121.4M | $594.2M | $744M | $423.6M | $433.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $80.6M | $283.6M | $118.2M | $124.4M | $120M | |
| Capital Expenditures | $2.7M | $3.5M | $3.4M | $4.8M | $3.9M | |
| Cash Acquisitions | -- | -- | -- | -- | $77.5M | |
| Cash From Investing | -$39M | -$1.3B | $91.4M | -$2.4M | -$18.7M | |
| Dividends Paid (Ex Special Dividend) | -$45.4M | -$46.7M | -$48.7M | -$50.1M | -$50.5M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $500M | -- | $2.5B | $1.5B | -- | |
| Long-Term Debt Repaid | -$550M | -- | -$1.9B | -$1.5B | -$10M | |
| Repurchase of Common Stock | -$11.2M | -$26.1M | -$1.4M | -$1M | -$20.3M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $712.5M | $64.9M | $532.5M | $11.8M | $216.6M | |
| Beginning Cash (CF) | $2.2B | $3.8B | $1.2B | $1.6B | $2.3B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $754.1M | -$955.1M | $742M | $133.7M | $317.9M | |
| Ending Cash (CF) | $3B | $2.8B | $1.9B | $1.7B | $2.6B | |
| Levered Free Cash Flow | $77.9M | $280.1M | $114.7M | $119.6M | $116.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $199.6M | $812.6M | $595.4M | $441.5M | $441.1M | |
| Capital Expenditures | $19.8M | $16.2M | $16.8M | $13M | $11.3M | |
| Cash Acquisitions | $629.1M | -- | -- | -- | $77.5M | |
| Cash From Investing | $221M | -$1.2B | -$2.1B | -$54.9M | $555.2M | |
| Dividends Paid (Ex Special Dividend) | -$171.9M | -$182.5M | -$195M | -$196.2M | -$201.1M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $600M | -- | $4.4B | $450M | -$1.2B | |
| Long-Term Debt Repaid | -$2.2B | -$47.8M | -$2.4B | -$1.5B | -$10M | |
| Repurchase of Common Stock | -$31.9M | -$26.1M | -$54.8M | -$1M | -$20.4M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $1.2B | $276.4M | $572.9M | -$572.6M | -$118.8M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.6B | -$160M | -$884.4M | -$186M | $877.5M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $179.8M | $796.4M | $578.6M | $428.4M | $429.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $80.6M | $283.6M | $118.2M | $124.4M | $120M | |
| Capital Expenditures | $2.7M | $3.5M | $3.4M | $4.8M | $3.9M | |
| Cash Acquisitions | -- | -- | -- | -- | $77.5M | |
| Cash From Investing | -$39M | -$1.3B | $91.4M | -$2.4M | -$18.7M | |
| Dividends Paid (Ex Special Dividend) | -$45.4M | -$46.7M | -$48.7M | -$50.1M | -$50.5M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $500M | -- | $2.5B | $1.5B | -- | |
| Long-Term Debt Repaid | -$550M | -- | -$1.9B | -$1.5B | -$10M | |
| Repurchase of Common Stock | -$11.2M | -$26.1M | -$1.4M | -$1M | -$20.3M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $712.5M | $64.9M | $532.5M | $11.8M | $216.6M | |
| Beginning Cash (CF) | $2.2B | $3.8B | $1.2B | $1.6B | $2.3B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $754.1M | -$955.1M | $742M | $133.7M | $317.9M | |
| Ending Cash (CF) | $3B | $2.8B | $1.9B | $1.7B | $2.6B | |
| Levered Free Cash Flow | $77.9M | $280.1M | $114.7M | $119.6M | $116.1M | |
Get UBSI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
UBSI
Sector
P/E ratio
13.93x
12.21x
PEG ratio
5.22x
0.40x
P/B ratio
1.00x
1.11x
Price / LTM sales
4.83x
2.66x
Growth Metrics
UBSI
Sector
Revenue growth
14.17%
5.12%
Earnings growth
-7.81%
2.63%
Revenue (5-year growth)
7.24%
5.17%
Earnings forecast
$0.78
$0.61
Profitability
UBSI
Sector
Profitability FY 2025
--
$138.7M
Return on invested capital
6.22%
5.21%
Return on assets
1.21%
0.97%
Return on equity
7.43%
9.24%
Earnings Date
Last Earnings Date
Apr
24
Next Earnings Date
Jul
25
Estimated Next Earnings Date
Jul
24
Balance Sheet
UBSI
Sector
Total cash
$2.9B
$451.2M
Short term investments
$261.5M
$220.9M
Total assets
$30B
$3.8B
Long term debt
$550.6M
$280.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
71
PGY alert for Jul 18
Pagaya Technologies [PGY] is up 4.92% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 0.03% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 9.69% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
